{"id":41258,"date":"2026-06-05T10:25:40","date_gmt":"2026-06-05T09:25:40","guid":{"rendered":"https:\/\/www.alantra.com\/?post_type=ib-transaction&p=41258"},"modified":"2026-06-05T14:28:44","modified_gmt":"2026-06-05T13:28:44","slug":"organicare-sell-side-advisory-venture-life-group-plc","status":"publish","type":"ib-transaction","link":"https:\/\/www.alantra.com\/de\/ib-transaction\/organicare-sell-side-advisory-venture-life-group-plc\/","title":{"rendered":"Alantra advises OrganiCare on the sale of FemiClear and Curoxen to Venture Life Group"},"content":{"rendered":"\n

New York \u2013 <\/strong>Alantra acted as exclusive financial advisor to OrganiCare, a U.S.-based consumer healthcare company, on the sale of its FemiClear\u00ae and Curoxen\u00ae brands to Venture Life Group plc (\u201cVLG\u201d), an international consumer self-care company.<\/p>\n\n\n\n

FemiClear and Curoxen are differentiated natural and homeopathic OTC consumer healthcare brands addressing the women\u2019s health and wound care categories. The acquisition expands VLG\u2019s presence in women\u2019s health through the addition of FemiClear and establishes a strategic foothold in the U.S. market, further strengthening the company\u2019s international consumer healthcare platform.<\/p>\n\n\n\n

Venture Life Group develops, manufactures and commercializes products across a range of health and wellness categories, including women\u2019s health, oral care, glucose management, oncology support and other self-care segments. The company has a commercial presence in more than 90 countries worldwide.<\/p>\n\n\n\n

Alantra drew on its consumer healthcare and OTC sector expertise to navigate the complexities associated with marketing and valuing homeopathic healthcare brands in the U.S. market. The team supported buyer diligence around the regulatory framework, commercial dynamics and growth opportunities underpinning the FemiClear and Curoxen brands, while managing a targeted cross-border process that resulted in a successful transaction for OrganiCare.<\/p>\n\n\n\n

Rusty Ray<\/a>, Managing Partner at Alantra, said: \u201cWe are pleased to have advised OrganiCare on this transaction, which brings FemiClear and Curoxen into a broader international consumer healthcare platform. The deal reflects continued strategic interest in differentiated self-care brands and highlights Alantra\u2019s ability to support cross-border consumer health transactions involving category-specific regulatory and commercial considerations.\u201d<\/p>\n\n\n\n

This transaction reinforces Alantra\u2019s activity in Consumer Health, with recent transactions including advising 21st Century Healthcare <\/a>on its sale to Grant Avenue Capital, Venture Life Group plc<\/a> on the sale of its CDMO business and selected non-core products to BioDue, and Perrigo <\/a>on the divestment of Richard Bittner to DCC Healthcare.<\/p>\n\n\n

\n
\n View United States <\/span><\/a>\n View Consumer Goods & Retail <\/span><\/a>\n <\/div>\n <\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

New York \u2013 Alantra acted as exclusive financial advisor to OrganiCare, a U.S.-based consumer healthcare company, on the sale of its FemiClear\u00ae and Curoxen\u00ae brands to Venture Life Group plc (\u201cVLG\u201d), an international consumer self-care company. FemiClear and Curoxen are differentiated natural and homeopathic OTC consumer healthcare brands addressing the women\u2019s health and wound care […]<\/p>\n","protected":false},"featured_media":41269,"parent":0,"template":"","meta":{"_acf_changed":true},"country":[32],"ib-service":[94],"sector":[48,52],"class_list":["post-41258","ib-transaction","type-ib-transaction","status-publish","has-post-thumbnail","hentry","country-united-states-of-america","ib-service-ma","sector-consumer-goods-retail","sector-healthcare"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.alantra.com\/de\/wp-json\/wp\/v2\/ib-transaction\/41258","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.alantra.com\/de\/wp-json\/wp\/v2\/ib-transaction"}],"about":[{"href":"https:\/\/www.alantra.com\/de\/wp-json\/wp\/v2\/types\/ib-transaction"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.alantra.com\/de\/wp-json\/wp\/v2\/media\/41269"}],"wp:attachment":[{"href":"https:\/\/www.alantra.com\/de\/wp-json\/wp\/v2\/media?parent=41258"}],"wp:term":[{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.alantra.com\/de\/wp-json\/wp\/v2\/country?post=41258"},{"taxonomy":"ib-service","embeddable":true,"href":"https:\/\/www.alantra.com\/de\/wp-json\/wp\/v2\/ib-service?post=41258"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/www.alantra.com\/de\/wp-json\/wp\/v2\/sector?post=41258"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}